Navigation Links
Dutch Top Institute Pharma Attracts International Interest
Date:9/10/2009

LEIDEN, The Netherlands, September 10 /PRNewswire/ -- The Danish Council for Strategic Research is visiting the Dutch Top Institute Pharma (TI Pharma) on Thursday, September 10. The purpose of their visit is to learn about the unique Dutch approach on public-private cooperation and the concrete results that are being booked by this institute. In the past, in the European Council, Denmark has cited TI Pharma as a prime example of public-private collaboration in the pharmaceutical sector and is considering following its lead.

In Denmark, TI Pharma is seen as a role model of public-private cooperation and partnership. "It is incredible how quickly TI Pharma has become established and also what the institute has accomplished in its first few years. The Netherlands initiated a clear strategy to support innovative pharmaceutical research and the government had the courage to reward this strategy with implementation. In European pharmaceutical research, TI Pharma is a role model of public-private cooperation and partnership", says Per Spindler, Board of Directors of the Drug Information Association (DIA) and Director of BioLogue/Danish Pharma Consortium (University of Copenhagen). [source: TI Pharma Annual Report 2008]

TI Pharma aims to develop the Netherlands into a European hotspot in innovative pharmaceutical research. Willem de Laat, Managing Director of TI Pharma: "We are excited to be able to share our experience and collaborate with other European countries that want to support top quality public-private partnerships in the life sciences and health field in order to address the most important needs in public health."

The Danish Council for Strategic Research was established in 2004 as an innovation within the Danish funding system for research. The Council consists of a Board and seven Programme Commissions. Within the Council, strategic research has a strong international dimens
'/>"/>

SOURCE TI Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Owensboro Medical Health System Announces Results of Its Modified Dutch Auction Tender Offer
2. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
3. Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
4. Dutch Fairytale Becomes Reality
5. Ty Cobb Healthcare Systems Announces Modified Dutch Auction Tender Offer for Its Revenue Anticipation Certificates, Series 1999
6. First Dutch Patients Treated With the Percutaneous MitraClip(R) System
7. UT public health policy expert says US can learn from Dutch universal health-care coverage
8. UT public health policy expert says US can learn from Dutch universal healthcare coverage
9. QLT to repurchase up to US$ 50 million of common shares - Modified "Dutch Auction" tender offer to commence on or about December 4, 2008
10. AGA Medical to Appeal Ruling by Dutch Court in Lawsuit With Occlutech GmbH
11. Global Intelligence Alliance Strengthens Group Organization and Adds Local Presence, Merges With Asian, German and Dutch Partner Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... London, UK (PRWEB) July 11, 2014 ... segment of the in-vitro diagnostics industry, which is expected ... next ten years. The sector owes its growth to ... threat to people’s health worldwide and a major factor ... diagnostic technologies, threat of bio-terrorism, and a broader availability ...
(Date:7/11/2014)... Utilizing the Keller Funnel, Quatela Center for ... a record number of complication-free breast augmentations. Far ... procedures without the occurrence of a capsular contraction. ... country for his expertise with the breast augmentation procedure. ... foundation for numerous studies and research. Most recently, ...
(Date:7/11/2014)... July 11, 2014 Ticket Down is ... Concord Pavilion . When it comes to the summer concert ... The 37-year-old Georgia native is one of the biggest names in ... business. Bryan is currently out on his “That’s My Kind of ... stops the tour will be making through the rest of the ...
(Date:7/11/2014)... July 11, 2014 Biostimulants are widely ... in turf and ornamentals. These also help turf and ... length of roots. Turf, ornamentals, and flowers appear healthy ... this usage has increased from the last few years. ... and ornamentals is Europe, with around 40% share in ...
(Date:7/11/2014)... kind has found that organic foods and crops ... counterparts, including more antioxidants and fewer, less frequent ... unprecedented 343 peer-reviewed publications comparing the nutritional quality ... including fruits, vegetables, and grains. The study team ... organic and non-organic foods. , "Science marches ...
Breaking Medicine News(10 mins):Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3
... Kathleen Doheny HealthDay Reporter , THURSDAY, Oct. 7 ... cancer who have dense breasts may be at higher risk ... breast, a new study indicates. "The risk appears to ... that originally had the cancer," said Laurel A. Habel, a ...
... (Oct. 7, 2010)In 2006, Dr. Shimya Yaminaka of Kyoto ... medicine research world on fire when he successfully transformed ... behave like embryonic stem cells. Embryonic stem cells, the ... the ability to differentiate into any type of tissue. ...
... which participants are randomly assigned to different treatments by ... correctly, it,s widely accepted by the research community that ... But researchers at the University of Michigan ... medical devices to patients by investigating the impact of ...
... HealthDay Reporter , WEDNESDAY, Oct. 6 (HealthDay News) ... be taken with the blood thinner Plavix, a new ... medications, called PPIs, might interfere with the ability of ... reassuring data that there is not any clinically significant ...
... perhaps more than anyone realizes -- in basic biological ... reducing cancer risks, according to University of Oregon researchers. ... zebrafish, scientists in the UO Institute of Molecular Biology ... in the sterile environment of its eggshell through the ...
... friends and family members of mood history and symptoms ... research published online by the journal International Psychogeriatrics ... who is highly outgoing and fun-loving and who is ... miss the signs that indicate the person is depressed. ...
Cached Medicine News:Health News:Denser Breasts Raise Odds of Second Breast Cancer, Study Finds 2Health News:Denser Breasts Raise Odds of Second Breast Cancer, Study Finds 3Health News:Colorado researcher discovers mechanism for changing adult cells into stem-like cells 2Health News:U-M receives NIH, FDA grant to study adaptive clinical trial designs 2Health News:Heartburn Drugs, Plavix Seem Safe to Take Together 2Health News:Heartburn Drugs, Plavix Seem Safe to Take Together 3Health News:Gut microbes promote cell turnover by a well-known pathway 2Health News:Patient personality hinders detection of depression 2
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
(Date:7/11/2014)... MELBOURNE, Australia , July 11, 2014  Australian ... today announced that it has raised A$19.3 million via ... Europe , the U.S., ... and A$3 million from a share purchase plan (SPP) ... A$16.3 million will be made in two tranches. ...
(Date:7/11/2014)... New York , July 11, 2014 ... by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic ... Size, Share, Growth, Trends and Forecast, 2013-2019" the global ... in 2012 and is expected to grow at a ... an estimated value of USD 36.9 billion in 2019. ...
Breaking Medicine Technology:Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... A. Grant, MD,Retina Macular Care, presented the ... that was designed to evaluate the adjuvant,use ... Lucentis(R),(ranibizumab) treatment of choroidal neovascularization secondary to,age-related ... presentation at,the 2008 Annual Meeting of the ...
... C Therapies Provides ... Clinical Practice, MILAN, Italy, April 26 Final ... study comparing the,leading therapies for chronic hepatitis C, were ... Association for the Study of the Liver,(EASL), providing important ...
Cached Medicine Technology:Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10